Valuation: Quanterix Corporation

Market Cap 131M 117M 108M 98.35M 185M 12.42B 188M 1.3B 510M 6.49B 492M 481M 20.75B P/E 2026 *
-1.42x
P/E 2027 * -2.24x
Enterprise Value 131M 117M 108M 98.35M 185M 12.42B 188M 1.3B 510M 6.49B 492M 481M 20.75B EV / Sales 2026 *
0.91x
EV / Sales 2027 * 0.83x
Free-Float
93.63%
Yield 2026 *
-
Yield 2027 * -
1 day-0.36%
1 week-12.70%
Current month-25.88%
1 month-9.54%
3 months-29.49%
6 months-16.67%
Current year-56.76%
1 week 2.72
Extreme 2.72
3.23
1 month 2.72
Extreme 2.72
3.98
Current year 2.15
Extreme 2.15
8.77
1 year 2.15
Extreme 2.15
8.77
3 years 2.15
Extreme 2.15
29.7
5 years 2.15
Extreme 2.15
60.92
10 years 2.15
Extreme 2.15
92.57
Manager TitleAgeSince
Chief Executive Officer 59 19/01/2026
Director of Finance/CFO 50 22/06/2026
Chief Tech/Sci/R&D Officer - 01/09/2026
Director TitleAgeSince
Director/Board Member 63 06/06/2022
Chairman 64 24/03/2025
Director/Board Member 48 19/08/2024
Date Insider Type Main position Quantity % Market Cap. Importance
15/10/26 Exercice

Chief Technology Officer

3,583 0.0077%
02/10/26 Exercice

Director

8,448 0.0182%
01/10/26 Free

Director

4,398 0.0095%
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%-12.70%-53.39%-85.93% 131M
+0.70%+2.79%+25.32%+46.77% 251B
-0.26%+0.70%+7.68%+9.02% 158B
+0.47%+3.23%-4.97%+63.23% 153B
+1.41%+5.86%-54.39%-8.39% 65.29B
+1.10%+3.88%-14.27%-9.85% 51.23B
+0.54%+5.44%+11.24%+58.72% 51.29B
+0.37%+3.06%+16.72%+26.48% 50.27B
+0.54%-0.70%+19.16%+56.01% 47.9B
+0.46%+1.29%+26.67%+71.39% 42.67B
Average +0.54%+0.72%-2.02%+22.75% 87.08B
Weighted average by Cap. +0.55%+2.64%+6.89%+36.58%

Financials

2026 *2027 *
Net sales 143M 128M 118M 108M 202M 13.59B 205M 1.42B 558M 7.1B 538M 527M 22.71B 158M 141M 130M 118M 222M 14.95B 226M 1.56B 614M 7.81B 591M 579M 24.97B
Net income -87.98M -78.42M -72.65M -66.05M -124M -8.34B -126M -871M -343M -4.36B -330M -323M -13.94B -82.03M -73.12M -67.74M -61.59M -116M -7.78B -117M -812M -319M -4.06B -308M -301M -12.99B
Net Debt - -
Projected Income Statement - Annual - Quanterix Corporation
Logo Quanterix Corporation
Quanterix Corporation is a life sciences company. The Company is focused on ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development proprietary digital Simoa detection technology enables customers to reliably detect protein biomarkers at ultra-low concentrations in blood, serum and other fluids that, in many cases, are undetectable using conventional, analog immunoassay technologies. Its Simoa bead-based digital immunoassays utilize the basic principles of conventional bead-based sandwich ELISA. The HD-X is the Company's flagship instrument that empowers biomarker research and accelerates drug development. Its SR-X instrument is a compact benchtop instrument with a lower price point, more flexible assay preparation, and a wider range of applications. The Company's Spatial Biology solutions measure protein expression and cellular phenotypes within intact tissue while preserving spatial context and tissue architecture.
Employees
450
Date Price Change Volume
20/10/26 $2.750 -0.72% 10,227
19/10/26 $2.770 -3.48% 430,148
16/10/26 $2.870 -6.51% 323,235
15/10/26 $3.070 +0.33% 291,060
14/10/26 $3.060 -2.86% 342,289
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
MarketScreener Ratings - Quanterix Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
2.770USD
Average target price
3.167USD
Spread / Average Target
+14.32%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Quanterix Corporation
  1. Stock Market
  2. Stocks
  3. QTRX Stock